May 29, 2026 08:41AM
May 26, 2026 08:25AM
May 12, 2026 08:41AM
May 5, 2026 08:53AM
Apr 20, 2026 04:03PM
Apr 20, 2026 07:15AM
Apr 14, 2026 07:32AM Clearmind Medicine's CMND-100 meets primary endpoint in phase trial
Mar 30, 2026 08:32AM
Mar 17, 2026 09:15AM
Mar 13, 2026 07:46AM
Mar 11, 2026 09:08AM
Mar 10, 2026 08:59AM
Mar 4, 2026 07:30AM
Feb 19, 2026 04:15PM LDB Capital Corp. Announces Definitive Agreement for Proposed Qualifying Transaction with Eventer Technologies Ltd.
Feb 9, 2026 08:17AM
Feb 9, 2026 08:17AM
Feb 9, 2026 08:00AM
Feb 6, 2026 08:02AM
Feb 6, 2026 07:57AM
Jan 14, 2026 08:55AM
Dec 24, 2025 09:15AM Clearmind Medicine advances alcohol disorder drug trial, reports safety data
Dec 16, 2025 08:45AM
Dec 5, 2025 05:01PM
Dec 2, 2025 07:57AM
Dec 1, 2025 08:57AM
Nov 26, 2025 04:18PM
Nov 25, 2025 07:17AM
Nov 24, 2025 08:51AM Clearmind Medicine receives approval to continue phase I trial
Nov 20, 2025 06:45AM
Nov 20, 2025 06:01AM
Nov 18, 2025 08:57AM
Nov 17, 2025 07:55AM
Nov 10, 2025 08:07AM
Nov 5, 2025 06:55AM
Oct 31, 2025 07:35AM Clearmind Medicine files U.S. patent application for cocaine addiction therapy
Oct 30, 2025 07:55AM
Oct 27, 2025 09:22AM
Oct 21, 2025 07:25AM
Oct 20, 2025 07:42AM
Sep 19, 2025 04:22PM
Sep 19, 2025 08:20AM
Aug 7, 2025 07:32AM Clearmind Medicine receives patent publication for obesity therapy
Jul 30, 2025 08:21AM
Jul 23, 2025 08:55AM
Jul 15, 2025 08:05AM
Jul 3, 2025 08:47AM
Jun 30, 2025 09:16AM
Jun 27, 2025 09:00AM
Jun 25, 2025 07:49AM Clearmind Medicine (CMND) Enrolls First Patient in its Clinical Trial for Alcoholism Treatment
Jun 23, 2025 07:58AM

397,225 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All